# Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients

> **NCT00818818** · PHASE4 · COMPLETED · sponsor: **University of Brasilia** · enrollment: 13 (actual)

## Conditions studied

- Localized Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Meglumine antimoniate

## Key facts

- **NCT ID:** NCT00818818
- **Lead sponsor:** University of Brasilia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-01
- **Final completion:** 2010-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2010-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818818, "Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00818818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*